| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.19▼ | 1.20▼ | 1.20▼ | 1.19▼ | 1.20▼ |
| MA10 | 1.20▼ | 1.18▼ | 1.18▼ | 1.21▼ | 1.39▼ |
| MA20 | 1.20▼ | 1.17▲ | 1.18▼ | 1.21▼ | 1.59▼ |
| MA50 | 1.18▼ | 1.18▼ | 1.18▼ | 1.49▼ | 2.29▼ |
| MA100 | 1.18▼ | 1.19▼ | 1.24▼ | 1.66▼ | 2.58▼ |
| MA200 | 1.19▼ | 1.24▼ | 1.27▼ | 2.10▼ | 6.91▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | 0.005▲ | 0.005▲ | 0.013▲ | -0.024▼ |
| RSI | 43.446▼ | 48.445▼ | 47.734▼ | 40.163▼ | 36.191▼ |
| STOCH | 37.413 | 70.701 | 65.720 | 20.308 | 15.335▼ |
| WILL %R | -84.615▼ | -68.750 | -61.111 | -86.441▼ | -85.577▼ |
| CCI | -102.366▼ | -27.559 | 4.881 | -72.091 | -84.669 |
|
Wednesday, September 23, 2026 07:20 AM
Annovis Bio (NYSE: ANVS) announced a collaboration with Weave Bio to support preparation of the planned New Drug Application (“NDA”) for buntanetap, its investigational oral therapy for ...
|
|
Thursday, August 27, 2026 05:00 PM
Roth Capital analyst Boobalan Pachaiyappan maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $8 to $7. Roth Capital analyst Boobalan Pachaiyappan initiates coverage on ...
|
|
Thursday, May 07, 2026 06:15 AM
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Annovis Bio (NYSE: ANVS), a Phase 3 clinical-stage ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/10/26 | 1.175 | 1.18 | 1.165 | 1.175 | 106,202 |
| 09/10/26 | 1.17 | 1.24 | 1.14 | 1.21 | 521,402 |
| 08/10/26 | 1.21 | 1.21 | 1.14 | 1.17 | 815,369 |
| 07/10/26 | 1.17 | 1.23 | 1.16 | 1.21 | 429,477 |
| 06/10/26 | 1.20 | 1.24 | 1.17 | 1.18 | 538,703 |
| 05/10/26 | 1.16 | 1.20 | 1.135 | 1.20 | 657,403 |
| 02/10/26 | 1.19 | 1.1964 | 1.135 | 1.18 | 644,360 |
| 01/10/26 | 1.27 | 1.28 | 1.16 | 1.17 | 1,188,211 |
| 30/09/26 | 1.30 | 1.335 | 1.27 | 1.27 | 572,977 |
| 29/09/26 | 1.39 | 1.41 | 1.30 | 1.30 | 811,961 |
|
|
||||
|
|
||||
|
|